| pubmed-article:10078083 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10078083 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
| pubmed-article:10078083 | lifeskim:mentions | umls-concept:C0004238 | lld:lifeskim |
| pubmed-article:10078083 | lifeskim:mentions | umls-concept:C0004239 | lld:lifeskim |
| pubmed-article:10078083 | lifeskim:mentions | umls-concept:C0037707 | lld:lifeskim |
| pubmed-article:10078083 | lifeskim:mentions | umls-concept:C0082966 | lld:lifeskim |
| pubmed-article:10078083 | lifeskim:mentions | umls-concept:C0456387 | lld:lifeskim |
| pubmed-article:10078083 | lifeskim:mentions | umls-concept:C0450442 | lld:lifeskim |
| pubmed-article:10078083 | lifeskim:mentions | umls-concept:C0680218 | lld:lifeskim |
| pubmed-article:10078083 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:10078083 | lifeskim:mentions | umls-concept:C1707454 | lld:lifeskim |
| pubmed-article:10078083 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:10078083 | pubmed:dateCreated | 1999-3-18 | lld:pubmed |
| pubmed-article:10078083 | pubmed:abstractText | To compare the efficacy and safety of a single dose of ibutilide, a new class III antiarrhythmic drug, with that of DL-sotalol in terminating chronic atrial fibrillation or flutter in haemodynamically stable patients. | lld:pubmed |
| pubmed-article:10078083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10078083 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:10078083 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10078083 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10078083 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:10078083 | pubmed:issn | 1355-6037 | lld:pubmed |
| pubmed-article:10078083 | pubmed:author | pubmed-author:HarryJ DJD | lld:pubmed |
| pubmed-article:10078083 | pubmed:author | pubmed-author:WellensH JHJ | lld:pubmed |
| pubmed-article:10078083 | pubmed:author | pubmed-author:SteinbeckGG | lld:pubmed |
| pubmed-article:10078083 | pubmed:author | pubmed-author:TouboulPP | lld:pubmed |
| pubmed-article:10078083 | pubmed:author | pubmed-author:RudR CRC | lld:pubmed |
| pubmed-article:10078083 | pubmed:author | pubmed-author:StanglKK | lld:pubmed |
| pubmed-article:10078083 | pubmed:author | pubmed-author:RudaM YMY | lld:pubmed |
| pubmed-article:10078083 | pubmed:author | pubmed-author:PerryK TKT | lld:pubmed |
| pubmed-article:10078083 | pubmed:author | pubmed-author:GolitsynS RSR | lld:pubmed |
| pubmed-article:10078083 | pubmed:author | pubmed-author:Van WijkL VLV | lld:pubmed |
| pubmed-article:10078083 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10078083 | pubmed:volume | 79 | lld:pubmed |
| pubmed-article:10078083 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10078083 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10078083 | pubmed:pagination | 568-75 | lld:pubmed |
| pubmed-article:10078083 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:10078083 | pubmed:meshHeading | pubmed-meshheading:10078083... | lld:pubmed |
| pubmed-article:10078083 | pubmed:meshHeading | pubmed-meshheading:10078083... | lld:pubmed |
| pubmed-article:10078083 | pubmed:meshHeading | pubmed-meshheading:10078083... | lld:pubmed |
| pubmed-article:10078083 | pubmed:meshHeading | pubmed-meshheading:10078083... | lld:pubmed |
| pubmed-article:10078083 | pubmed:meshHeading | pubmed-meshheading:10078083... | lld:pubmed |
| pubmed-article:10078083 | pubmed:meshHeading | pubmed-meshheading:10078083... | lld:pubmed |
| pubmed-article:10078083 | pubmed:meshHeading | pubmed-meshheading:10078083... | lld:pubmed |
| pubmed-article:10078083 | pubmed:meshHeading | pubmed-meshheading:10078083... | lld:pubmed |
| pubmed-article:10078083 | pubmed:meshHeading | pubmed-meshheading:10078083... | lld:pubmed |
| pubmed-article:10078083 | pubmed:meshHeading | pubmed-meshheading:10078083... | lld:pubmed |
| pubmed-article:10078083 | pubmed:meshHeading | pubmed-meshheading:10078083... | lld:pubmed |
| pubmed-article:10078083 | pubmed:meshHeading | pubmed-meshheading:10078083... | lld:pubmed |
| pubmed-article:10078083 | pubmed:meshHeading | pubmed-meshheading:10078083... | lld:pubmed |
| pubmed-article:10078083 | pubmed:meshHeading | pubmed-meshheading:10078083... | lld:pubmed |
| pubmed-article:10078083 | pubmed:meshHeading | pubmed-meshheading:10078083... | lld:pubmed |
| pubmed-article:10078083 | pubmed:meshHeading | pubmed-meshheading:10078083... | lld:pubmed |
| pubmed-article:10078083 | pubmed:meshHeading | pubmed-meshheading:10078083... | lld:pubmed |
| pubmed-article:10078083 | pubmed:meshHeading | pubmed-meshheading:10078083... | lld:pubmed |
| pubmed-article:10078083 | pubmed:meshHeading | pubmed-meshheading:10078083... | lld:pubmed |
| pubmed-article:10078083 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:10078083 | pubmed:articleTitle | Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group. | lld:pubmed |
| pubmed-article:10078083 | pubmed:affiliation | Department of Cardiology, University Hospital Maastricht, Netherlands. | lld:pubmed |
| pubmed-article:10078083 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10078083 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10078083 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:10078083 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:10078083 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:10078083 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10078083 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10078083 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10078083 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10078083 | lld:pubmed |
